Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

by Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
Published 2008-10-01